Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation.

Date publication

janvier 2016

Journal

Alimentary pharmacology & therapeutics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Coimbra AJ, Rimola J, O'Byrne S, Lu TT, Bengtsson T, de Crespigny A, Luca D, Rutgeerts P, Bruining DH, Fidler JL, Sandborn WJ, Santillan CS, Higgins PD, Al-Hawary MM, Vermeire S, Vanbeckevoort D, Vanslembrouck R, Peyrin-Biroulet L, Laurent V, Herrmann KA, Panes J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26548868

Résumé

Reliable tools for patient selection are critical for clinical drug trials.

Mots clés

Adult, Colon, pathology, Crohn Disease, pathology, Endoscopy, Gastrointestinal, methods, Female, Humans, Ileum, pathology, Inflammation, pathology, Magnetic Resonance Spectroscopy, methods, Male, Middle Aged, Multicenter Studies as Topic, methods, Patient Selection, Reproducibility of Results

Référence

Aliment. Pharmacol. Ther.. 2016 Jan;43(1):61-72